Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Bruker (BRKR) Net Cash Flow (2016 - 2026)

Bruker filings provide 16 years of Net Cash Flow readings, the most recent being $6.7 million for Q4 2025.

On a quarterly basis, Net Cash Flow fell 87.68% to $6.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $72.7 million, a 126.32% increase, with the full-year FY2025 number at $72.7 million, up 126.32% from a year prior.
Net Cash Flow hit $6.7 million in Q4 2025 for Bruker, down from $201.4 million in the prior quarter.
In the past five years, Net Cash Flow ranged from a high of $494.3 million in Q4 2021 to a low of -$241.4 million in Q1 2022.
Median Net Cash Flow over the past 5 years was -$29.5 million (2021), compared with a mean of -$17.8 million.
Biggest five-year swings in Net Cash Flow: plummeted 772.42% in 2022 and later soared 882.73% in 2023.
Bruker's Net Cash Flow stood at $494.3 million in 2021, then tumbled by 102.81% to -$13.9 million in 2022, then soared by 882.73% to $108.8 million in 2023, then crashed by 50.0% to $54.4 million in 2024, then crashed by 87.68% to $6.7 million in 2025.
The last three reported values for Net Cash Flow were $6.7 million (Q4 2025), $201.4 million (Q3 2025), and -$123.1 million (Q2 2025) per Business Quant data.